Encompass Health Corp
NYSE:EHC
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
91.05
127.18
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Encompass Health Corp
Encompass Health Corporation has carved a distinctive niche in the healthcare industry as a leading provider of rehabilitation services. Formed through the combination of HealthSouth Corporation and Encompass Home Health & Hospice, the company leverages its extensive network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies to deliver high-quality rehabilitative care across the United States. Operating in a field that requires precision and empathy, Encompass Health focuses on helping patients regain their independence after illnesses, injuries, or surgeries. The company's business model is centered around patient recovery, wherein they use a team-based approach involving physicians, therapists, and nurses, further enriched by state-of-the-art technology and evidence-based practices. Their inpatient rehabilitation hospitals offer specialized programs that significantly reduce the time and cost of patient recovery compared to general hospitals, thereby attracting a steady flow of referrals from healthcare providers.
Financially, Encompass Health derives its revenue by billing patients' insurance providers, including Medicare and Medicaid, based on the services rendered during the patients' recovery process. By primarily focusing on inpatient rehabilitation and home health services, segments that are in high demand due to the aging population and rising prevalence of chronic conditions, the company has positioned itself well for sustainable growth. The strategic expansion of their footprint through acquisitions and organic growth, along with innovative treatment offerings, enhances their market reach and capacity. This operational strategy not only ensures a steady revenue stream but also buffers against the inherent uncertainties in the healthcare landscape. Balancing regulatory compliance with exceptional patient care, Encompass Health thrives in a competitive industry, continually adapting to shifts in healthcare policy while maintaining a strong emphasis on patient outcomes.
Encompass Health Corporation has carved a distinctive niche in the healthcare industry as a leading provider of rehabilitation services. Formed through the combination of HealthSouth Corporation and Encompass Home Health & Hospice, the company leverages its extensive network of inpatient rehabilitation hospitals, home health agencies, and hospice agencies to deliver high-quality rehabilitative care across the United States. Operating in a field that requires precision and empathy, Encompass Health focuses on helping patients regain their independence after illnesses, injuries, or surgeries. The company's business model is centered around patient recovery, wherein they use a team-based approach involving physicians, therapists, and nurses, further enriched by state-of-the-art technology and evidence-based practices. Their inpatient rehabilitation hospitals offer specialized programs that significantly reduce the time and cost of patient recovery compared to general hospitals, thereby attracting a steady flow of referrals from healthcare providers.
Financially, Encompass Health derives its revenue by billing patients' insurance providers, including Medicare and Medicaid, based on the services rendered during the patients' recovery process. By primarily focusing on inpatient rehabilitation and home health services, segments that are in high demand due to the aging population and rising prevalence of chronic conditions, the company has positioned itself well for sustainable growth. The strategic expansion of their footprint through acquisitions and organic growth, along with innovative treatment offerings, enhances their market reach and capacity. This operational strategy not only ensures a steady revenue stream but also buffers against the inherent uncertainties in the healthcare landscape. Balancing regulatory compliance with exceptional patient care, Encompass Health thrives in a competitive industry, continually adapting to shifts in healthcare policy while maintaining a strong emphasis on patient outcomes.
Revenue Growth: Encompass Health delivered 9.4% revenue growth in Q3 2025, with year-to-date revenue up 10.6%.
Profitability: Adjusted EBITDA grew 11.4% in the quarter and 14.5% year-to-date.
Guidance Raised: Management increased 2025 guidance for revenue, adjusted EBITDA, adjusted EPS, and free cash flow.
Capacity Expansion: The company is further accelerating plans to add beds, with increased targets for 2025–2027, reflecting strong and underserved demand.
Labor Management: Labor costs remained well controlled, with premium labor spend dropping to its lowest level since early 2021 and turnover rates at pre-pandemic levels.
ERP System Launch: Successfully converted to the Oracle Fusion ERP system with only minor issues.
Payer Mix & Volumes: Growth was balanced across Medicare, Medicare Advantage, managed care, and VA, with VA volume up over 25% year-over-year.
No Major Surprises: The quarter came in line with expectations, aside from provider tax revenue timing.
